Glimepiride + Pioglitazone + Metformin Hcl (Sustain Release) Tablets Each uncoated tablet contains: Glimepiride B.P. 2mg Pioglitazone HCl B.P. Eq. to Pioglitazone 15mg Metformin HCl B.P. 500.
IndicationsIn Non-insulin dependent or Type 2 diabetes mellitus, Polycystic ovary syndrome.
Packing10 x 10 Tab. Blister
Glimepiride + Voglibose+ Metformin HCl Tablets Each uncoated tablet contains: Glimepiride B.P. 1mg Voglibose B.P. 0.2mg Metformin HCl B.P. 500mg (As sustain release).
IndicationsIn Non-insulin dependent or Type 2 diabetes mellitus, Polycystic ovary syndrome.
Packing10 x 10 Tab. Blister
Metformin Hydrochloride + Glimepiride Tablets (As Sustain Release Form) Each uncoated tablet contains Metformin HCl B.P. 1000mg (as sustain release form) Glimepiride B.P. 4mg.
IndicationsMaturity onset (non-insulin dependent) diabetes. Polycystic ovary syndrome.
Packing10 x 10 Tab. Blister
Gliclazide + Metformin Tablets Each tablet contains Gliclazide B.P. 80mg Metformin HCl B.P. 500mg.
IndicationsMaturity onset (non-insulin dependent) diabetes. Polycystic ovary syndrome.
Packing10 x 10 Tab. Blister
Metformin Tablets BP Each Film Coated tablet Contains: Metformin HCl B.P....500 mg.
IndicationsMaturity onset (non-insulin dependent) diabetes. Polycystic ovary syndrome.
Packing10 x 10 Tab. Blister